Type 1 helper t cell-increasing agent, food and pharmaceutical
AssigneeDaicel Corporation
InventorsHiroshi Ohno, Tadashi Takeuchi, Shu Shimamoto, Shuuji Yoshioka, Eiji Miyauchi, Hiroki Negishi
Life of this patent
Estimating the term…
Abstract
An object is to provide a Th1-increasing agent that can reduce constraints on storage conditions and feeding form and sufficiently increase Th1 at lower doses. A Th1-increasing agent containing a cellulose derivative as an active ingredient, the cellulose derivative having a degree of butyryl substitution of 0.3 or greater and 2.6 or less, and a total degree of substitution of 0.5 or greater and 2.8 or less.
Claims11
A method of increasing type 1 helper T cells, which comprises administering a type 1 helper T cell-increasing agent comprising a cellulose derivative as an active ingredient, the cellulose derivative having a degree of butyryl substitution of 0.3 or greater and 2.6 or less, and a total degree of substitution of 0.5 or greater and 2.8 or less, wherein the increase in type 1 helper T cells treats and/or reduces the likelihood of a tumor.
A method of increasing INF-γ-producing cells, which comprises administering an INF-γ-producing cell-increasing agent comprising a cellulose derivative as an active ingredient, the cellulose derivative having a degree of butyryl substitution of 0.3 or greater and 2.6 or less, and a total degree of substitution of 0.5 or greater and 2.8 or less.
Dependencies are inferred from the claim text.